Depression before and after diagnostic procedures among women with abnormal finding of Papanicolaou screening test
- PMID: 35322940
- PMCID: PMC9487877
- DOI: 10.1002/cam4.4709
Depression before and after diagnostic procedures among women with abnormal finding of Papanicolaou screening test
Abstract
Background: Some studies did find significant differences in the level of depression of women while undergoing diagnostic evaluation of an abnormal Papanicolaou screening smear, but findings were not consistent. This study aimed to assess prevalence and correlates of depression in women with abnormal cervical screening results before and after diagnostic procedures.
Methods: A cross-sectional study was carried out during 2017 in a cohort of women with positive Papanicolaou screening test before and after diagnostic procedures (colposcopy/biopsy/endocervical curettage) at the university Clinical Centre Kragujevac, Serbia. Women completed a questionnaire about demographics, lifestyle, and other factors of interest. Also, questionnaire "Hospital Anxiety and Depression Scale" (HADS) was used immediately before and 2-4 weeks after the diagnostic procedures: a score of ≥8 on HADS-D and HADS-A subscales indicated depression and anxiety, respectively. Multivariate logistic regression was applied in the data analysis.
Results: The study comprised 172 women, giving a response rate of 72.3%. The mean age of the participants was 47.8 ± 11.1 years (range 23-65). The frequency of depressive symptoms was significantly higher after diagnostic procedures (48.3%) than before diagnostic procedures (37.2%) (p = 0.038). Before diagnostic procedures, older age (OR = 1.60; 95% CI = 1.09-2.34; p = 0.017), and level of anxiety according to the HADS-A subscale (OR = 1.61; 95% CI = 1.38-1.88; p < 0.001) were significant independent predictors of depression. After diagnostic procedures, significant independent predictors of depression were urban place of residence (OR = 0.12; 95% CI = 0.03-0.47; p = 0.002) and level of anxiety according to the HADS-A subscale (OR = 1.85; 95% CI = 1.54-2.21; p < 0.001).
Conclusion: Our study showed that older age, rural residence, and anxiety play a role in shaping the risk of depression among women undergoing additional diagnostic procedures after receiving an abnormal Papanicolaou screening result.
Keywords: Papanicolaou smear; cervical cancer screening; depression; diagnostic procedures.
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
No potential conflict of interest.
Similar articles
-
Predictors of Anxiety Before and After Diagnostic Procedures in Women with Abnormal Papanicolaou Smear in Cervical Cancer Screening Program.Behav Med. 2024 Apr-Jun;50(2):118-129. doi: 10.1080/08964289.2022.2132202. Epub 2022 Oct 21. Behav Med. 2024. PMID: 36268786
-
Predictors of depressive symptoms before and after diagnostic procedures in women with abnormal Pap smear attending cervical cancer screening programme in Serbia.Eur J Cancer Care (Engl). 2022 Sep;31(5):e13634. doi: 10.1111/ecc.13634. Epub 2022 Jun 13. Eur J Cancer Care (Engl). 2022. PMID: 35697508
-
Detecting the impact of diagnostic procedures in Pap-positive women on anxiety using artificial neural networks.PLoS One. 2024 Oct 31;19(10):e0312870. doi: 10.1371/journal.pone.0312870. eCollection 2024. PLoS One. 2024. PMID: 39480895 Free PMC article.
-
Internal consistency and validity of the Hospital Anxiety and Depression Scale (HADS) in women with abnormal Pap smear in Serbia.Women Health. 2021 Apr;61(4):363-371. doi: 10.1080/03630242.2021.1893244. Epub 2021 Feb 28. Women Health. 2021. PMID: 33641629
-
Psychological Distress in Women With Abnormal Pap Smear Results Attending Cervical Cancer Screening.J Low Genit Tract Dis. 2023 Oct 1;27(4):343-350. doi: 10.1097/LGT.0000000000000761. Epub 2023 Aug 3. J Low Genit Tract Dis. 2023. PMID: 37535069
Cited by
-
Psychosocial Burden of Women Who Are to Undergo Additional Diagnostic Procedures Due to Positive Screening for Cervical Cancer.Cancers (Basel). 2024 Oct 20;16(20):3541. doi: 10.3390/cancers16203541. Cancers (Basel). 2024. PMID: 39456635 Free PMC article.
-
Validity of the process and outcome specific measure in women with abnormal Papanicolaou screening test.PLoS One. 2025 Jun 3;20(6):e0325131. doi: 10.1371/journal.pone.0325131. eCollection 2025. PLoS One. 2025. PMID: 40460080 Free PMC article.
References
-
- International Agency for Research on Cancer . Cancer incidence in five continents. Vol. XI (electronic version). 2021: International Agency for Research on Cancer. Available from: http://ci5.iarc.fr. Accessed 20/09/2021
-
- Vaccarella S, Laversanne M, Ferlay J, Bray F. Cervical cancer in Africa, Latin America and the Caribbean and Asia: regional inequalities and changing trends. Int J Cancer. 2017;141(10):1997‐2001. - PubMed